Factors associated with masticatory function as measured with the Mixing Ability Test in patients with head and neck cancer before and after treatment: a prospective cohort study

被引:2
作者
Vermaire, Jorine A. [1 ]
Raaijmakers, Cornelis P. J. [1 ]
Monninkhof, Evelyn M. [2 ]
Verdonck-de Leeuw, Irma M. [3 ,4 ,5 ]
Terhaard, Chris H. J. [1 ]
Speksnijder, Caroline M. [6 ,7 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Radiat Oncol, Imaging Div, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Vrije Univ Amsterdam, Dept Otolaryngol Head & Neck Surg, Amsterdam UMC, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands
[6] Univ Utrecht, Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg & Special Dent Car, G05-122,POB 85-500, NL-3508 GA Utrecht, Netherlands
[7] Univ Utrecht, Univ Med Ctr Utrecht, Dept Head & Neck Surg Oncol, Utrecht, Netherlands
关键词
Mixing Ability Test; Mastication; Linear mixed-effects model; Associative model; Head and neck cancer; ADVANCED ORAL-CANCER; QUALITY-OF-LIFE; PREDICTORS; PERCEPTION; MOUTH;
D O I
10.1007/s00520-022-06867-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose After treatment for head and neck cancer (HNC), patients often experience major problems in masticatory function. The aim of this prospective cohort study among patients with HNC was to investigate which personal and clinical factors are associated with masticatory function from diagnosis up to 2 years after treatment with curative intent. Methods Masticatory function was measured using the Mixing Ability Test (MAT) before treatment (baseline), and 3, 6, 12, and 24 months after treatment. A linear mixed-effects model with a random intercept and slope was conducted to investigate changes over time and the association with personal (sex, age) and clinical (tumor site, tumor stage, treatment modality) factors as measured at baseline. Result One-hundred-twenty-five patients were included. The prevalence of masticatory dysfunction was estimated at 29% at M0, 38% at M3, 28% at M6, 26% at M12, and 36% at M24. A higher (worse) MAT score was associated with age, tumor stage, tumor site, timing of assessment, and the interaction between assessment moment and tumor site. Conclusion In patients with HNC, masticatory function changed over time and dysfunction was associated with a higher age, a tumor in the oral cavity, a higher tumor stage, and a shorter time since treatment. The prevalence of masticatory dysfunction ranged from 26 to 38%.
引用
收藏
页码:4429 / 4436
页数:8
相关论文
共 50 条
  • [41] Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study
    Mazumder, Md Taher Ahmed
    Phookan, Jyotirmoy
    Saikia, Nabajyoti
    Sarmah, Monikuntal
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (01) : MC5 - MC9
  • [42] Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment
    Ventura, Talita Mendes Oliveira
    Ribeiro, Nathalia Regina
    Taira, Even Akemi
    de Lima Leite, Aline
    Dionizio, Aline
    Rubira, Cassia Maria Fischer
    da Silva Santos, Paulo Sergio
    Buzalaf, Marilia Afonso Rabelo
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (01) : 225 - 258
  • [43] Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment
    Talita Mendes Oliveira Ventura
    Nathalia Regina Ribeiro
    Even Akemi Taira
    Aline de Lima Leite
    Aline Dionizio
    Cássia Maria Fischer Rubira
    Paulo Sérgio da Silva Santos
    Marília Afonso Rabelo Buzalaf
    Clinical Oral Investigations, 2022, 26 : 225 - 258
  • [44] Evolution of sexual health of patients with head and neck cancer before, during, and 1 year after treatment
    J. Pradier
    S. Togan
    C. Combe
    G. Buiret
    Supportive Care in Cancer, 2025, 33 (5)
  • [45] Unmet supportive care needs among informal caregivers of patients with head and neck cancer in the first 2 years after diagnosis and treatment: a prospective cohort study
    van Hof, Kira S.
    Hoesseini, Arta
    Dorr, Maarten C.
    Verdonck-de Leeuw, Irma M. M.
    Jansen, Femke
    Leemans, C. Rene
    Takes, Robert P.
    Terhaard, Chris H. J.
    de Jong, Robert J. Baatenburg
    Sewnaik, Aniel
    Offerman, Marinella P. J.
    SUPPORTIVE CARE IN CANCER, 2023, 31 (05)
  • [46] Unmet supportive care needs among informal caregivers of patients with head and neck cancer in the first 2 years after diagnosis and treatment: a prospective cohort study
    Kira S. van Hof
    Arta Hoesseini
    Maarten C. Dorr
    Irma M. Verdonck - de Leeuw
    Femke Jansen
    C. Réne Leemans
    Robert P. Takes
    Chris H. J. Terhaard
    Robert J. Baatenburg de Jong
    Aniel Sewnaik
    Marinella P. J. Offerman
    Supportive Care in Cancer, 2023, 31
  • [47] Evolution and predictive factors of quality of life in patients undergoing oncologic surgery for head and neck cancer: A prospective multicentric study
    Bozec, Alexandre
    Schultz, Philippe
    Gal, Jocelyn
    Chamorey, Emmanuel
    Chateau, Yann
    Dassonville, Olivier
    Poissonnet, Gilles
    Demard, Francois
    Peyrade, Frederic
    Saada, Esma
    Benezery, Karen
    Leysalle, Axel
    Santini, Laure
    Messaoudi, Lila
    Fakhry, Nicolas
    SURGICAL ONCOLOGY-OXFORD, 2019, 28 : 236 - 242
  • [48] Poor nutrition status associated with low patient satisfaction six months into treatment for head and neck/esophageal cancer treatment: A prospective multicenter cohort study
    Widaman, Adrianne M.
    Day, Andrew G.
    Kuhn, Maggie A.
    Dhaliwal, Rupinder
    Baracos, Vickie
    Findlay, Merran
    Bauer, Judith D.
    de van der Schueren, Marian
    Laviano, Alessandro
    Martin, Lisa
    Gramlich, Leah
    NUTRITION IN CLINICAL PRACTICE, 2025, 40 (02) : 405 - 419
  • [49] A descriptive epidemiological study on the treatment options for head and neck cancer: Transition before and after approval of cetuximab
    Yamada, Shuhei
    Sato, Izumi
    Kawakami, Koji
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (03) : 330 - 336
  • [50] Resilience and its associated factors in head and neck cancer patients in Pakistan: an analytical cross-sectional study
    Zahid, Nida
    Zahid, Wajeeha
    Khalid, Wardah
    Azam, Iqbal
    Ikram, Mubasher
    Hassan, Aneesa
    Iftikar, Haissan
    Bhamani, Shireen Shehzad
    Jabbar, Adnan Abdul
    Akhtar, Shabbir
    Siddiqui, Moghira Iqbaluddin
    Awan, Mohammad Sohail
    Asad, Nargis
    Ahmad, Khabir
    BMC CANCER, 2021, 21 (01)